Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_062498ceb2040f4fbdfd3e07403d50cc |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6851 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P19-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-11 |
filingDate |
2008-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2015-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0ca1eb165e96b67d305edf49e3bf1fb8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a26f8a7848709d83976f289c9ac8443 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e082daceeace7476323132aca3148733 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_64a4dd1cbe180e6a2aeb1e5ce81d78c7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a69be46f5f23b0d0464505c28e9cceaf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_491e6a5ddd047ea5f7a6d470e8e1ea77 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c42225a3c867676a184d6bf99d926298 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a50f6957eef6ed3892627254005fca6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31254b8803da5a601613b0dbbee05719 |
publicationDate |
2015-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
AU-2008324675-B2 |
titleOfInvention |
Mitochondrial DNA deletion between about residues 12317-16254 for use in the detection of cancer |
abstract |
The present invention relates to methods for predicting, diagnosing and monitoring cancer. The methods comprise obtaining biological samples, extracting mitochondrial DNA (mtDNA) from the samples, quantifying a mtDNA mutation in the sample and comparing the level of the mtDNA mutation present in the sample with a reference value The methods of the invention may also be effective in screening for new therapeutic agents and treatment regimes Further, said methods may be also be useful for monitoring the response of a subject to a preventative or therapeutic treatment. |
priorityDate |
2007-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |